Reversible and irreversible protein glutathionylation: Biological and clinical aspects

Expert Opinion on Drug Metabolism and Toxicology

Volumn 7, Issue 7, 2011, Pages 891-910

  Cooper, Arthur J L ^a   Pinto, John T ^a   Callery, Patrick S ^b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

busulfan; glutathione; glutathione disulfide; irreversible protein glutathionylation; lanthionine; redox potential; reversible protein glutathionylation

Indexed keywords

BUSULFAN; BUTHIONINE SULFOXIMINE; CALCIUM; DEHYDROALANINE; DISULFIDE; FATTY ACID; GLUTATHIONE; HEPSULFAM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ION CHANNEL; LENS PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SULFENIC ACID DERIVATIVE; THIOL DERIVATIVE; TREOSULFAN;

ALZHEIMER DISEASE; APOPTOSIS; CALCIUM HOMEOSTASIS; CATARACT; CELL CYCLE; CHEMICAL REACTION; CYSTIC FIBROSIS; DRUG METABOLISM; DRUG STRUCTURE; ENERGY METABOLISM; FATTY ACID SYNTHESIS; HUMAN; IN VITRO STUDY; IRREVERSIBLE PROTEIN GLUTATHIONYLATION; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVERSIBLE PROTEIN GLUTATHIONYLATION; REVIEW; SIGNAL TRANSDUCTION;

ALANINE; ALDEHYDES; ALZHEIMER DISEASE; APOPTOSIS; BUSULFAN; CATARACT; CELL CYCLE; CYSTIC FIBROSIS; DIABETES MELLITUS, TYPE 2; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE TRANSFERASE; NEOPLASMS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN FOLDING; PROTEINS; SIGNAL TRANSDUCTION; SULFIDES;

EID: 79959221560     PISSN: 17425255     EISSN: 17447607     Source Type: Journal    
DOI: 10.1517/17425255.2011.577738     Document Type: Review

References (166)

1. Meister A. Biochemistry of Glutathione. In: Greenberg DM, editor, Metabolism of Sulfur Compounds. 3rd edition. Volume 7. Metabolic Pathways; 1975. p. 101-88 An earlier account of the biological importance of GSH by a pioneer in the field.
2. Meister A, Anderson MA. Glutathione. Annu Rev Biochem 1983;52:711-60 A good review of earlier work on the biological importance of GSH.
3. Sies H. Glutathione and its role in cellular functions. Free Radic Biol Med 1999;27:916-21 (Pubitemid 29507465)
4. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001;30:1191-212 An excellent account of the importance of the GSH-GSSG redox couple in controlling the cellular redox environment including thiol/disulfide switches in proteins and the relevance to biological processes.
5. Jacob C, Giles GI, Giles NM, et al. Sulfur and selenium: the role of oxidation state in protein structure and function. Angew Chem Int Ed Engl 2003;42:4742-58 (Pubitemid 37314599)
6. Shelton MD, Chock PB, Mieyal JJ. Glutaredoxin: role in reversible protein S-glutathionylation and regulation of redox signal transduction and protein translocation. Antioxid Redox Signal 2005;7:348-66 (Pubitemid 40279804)
7. Townsend DM. S-Glutathionylation: indicator of cell stress and regulator of the unfolded protein response. Mol Interv 2007;7:313-24 A good introduction to the biological importance of protein glutathionylation and possible biomedical implications.
8. Mieyal JJ, Gallogly MM, Qanungo S, et al. Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxid Redox Signal 2008;10:1941-88
9. Dalle-Donne I, Rossi R, Colombo G, et al. Protein S-glutathionylation: a regulatory device from bacteria to humans. Trends Biochem Sci 2009;34:85-96 An excellent account of the important biological roles of protein glutathionylation in nature.
10. Dalle-Donne I, Colombo G, Gagliano N, et al. S-Glutathiolation in life and death decisions of the cell. Free Radic Res 2010;10:545-52 A timely review on the recent findings of an important role for GSH in apoptosis.
11. Cooper AJL, Hanigan MH. Enzymes involved in processing of glutathione conjugates. In: McQueen CA, Guengerich FP, editors, Comprehensive Toxicology. 2nd edition. Volume 4. Biotransformations, Elsevier Press, Oxford, 2010. p. 323-65 This chapter describes the role of glutathione and the mercapturate pathway in the detoxification of potentially harmful endogenous and exogenous electrophiles.
12. Markovic J, García-Gimenez JL, Gimeno A, et al. Role of glutathione in cell nucleus. Free Radic Res 2010;44:721-33
13. Diaz Vivancos P, Wolff T, Markovic J, et al. A nuclear glutathione cycle within the cell cycle. Biochem J 2010;431:169-78 A good summary of the potential role of GSH in the cell cycle.
14. Garcia J, Han D, Sancheti H, et al. Regulation of mitochondrial glutathione redox status and protein glutathionylation by respiratory substrates. J Biol Chem 2010;285:39646-56 This paper describes the important role of glutathionylation of mitochondrial proteins as regulators of mitochondrial redox status and maintenance of mitochondrial NADPH levels.
15. Tew KD, Townsend DM. Redox platforms in cancer drug discovery and development. Curr Opin Chem Biol 2010;15:156-61 An excellent suggestion that intervention in protein glutathionylation may be of relevance in cancer treatment.
16. Cooper AJL, Pulsinelli WA, Duffy TE. Glutathione and ascorbate during ischemia and postischemic reperfusion in rat brain. J Neurochem 1980;35:1242-5 (Pubitemid 11198299)
17. Akerboom TP, Bilzer M, Sies H. The relationship of biliary glutathione disulfide efflux and intracellular glutathione disulfide content in perfused rat liver. J Biol Chem 1982;257:4248-52 (Pubitemid 12080147)
18. Rodkey FL. Oxidation-reduction potentials of the triphosphopyridine nucleotide system. J Biol Chem 1955;213:777-86
19. Harrison FE, May JM. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med 2009;46:719-30
20. Hofmann B, Hecht HJ, Flohe L. Peroxiredoxins. Biol Chem 2002;383:347-64
21. Mauri P, Benazzi L, Flohe L, et al. Versatility of selenium catalysis in PHGPx unraveled by LC/ESI-MS/MS. Biol Chem 2003;384:575-88 (Pubitemid 36609173)
22. Fratelli M, Goodwin LO, Orom UA, et al. Gene expression profiling reveals a signaling role of glutathione in redox regulation. Proc Natl Acad Sci USA 2005;102:13998-4003 (Pubitemid 41377692)
23. Seres T, Ravichandran V, Moriguchi T, et al. Protein S-thiolation and dethiolation during the respiratory burst in human monocytes. A reversible post-translational modification with potential for buffering the effects of oxidant stress. J Immunol 1996;156:1973-80 (Pubitemid 26069333)
24. Gallogly MM, Starke DW, Leonberg AK, et al. Kinetic and mechanistic characterization and versatile catalytic properties of mammalian glutaredoxin 2: implications for intracellular roles. Biochemistry 2008;47:11144-57
25. Starke DW, Chock PB, Mieyal JJ. Glutathione-thiyl radical scavenging and transferase properties of human glutaredoxin (thioltransferase). Potential role in redox signal transduction. J Biol Chem 2003;278:14607-13 (Pubitemid 36799782)
26. Lei K, Townsend DM, Tew KD. Protein cysteine sulfinic acid reductase (sulfiredoxin) as a regulator of cell proliferation and drug response. Oncogene 2008;27:4877-87
27. Jonsson TJ, Murray MS, Johnson LC, et al. Reduction of cysteine sulfinic acid in peroxiredoxin by sulfiredoxin proceeds directly through a sulfinic phosphoryl ester intermediate. J Biol Chem 2008;283:23846-51
28. Rehder DS, Borges CR. Cysteine sulfenic acid as an intermediate in disulfide bond formation and nonenzymatic protein folding. Biochemistry 2010;49:7748-55
29. Boot-Handford RP, Briggs MD. The unfolded protein response and its relevance to connective tissue diseases. Cell Tissue Res 2010;339:197-211
30. Ranaivoson FM, Neiers F, Kauffmann B, et al. Methionine sulfoxide reductase B displays a high level of flexibility. J Mol Biol 2009;394:83-93
31. Gates KS, Tanner JJ, Parsons ZD, et al. Redox regulation of protein tyrosine phosphatases: Structural and chemical aspects. Antioxid Redox Signal 2010. [Epub ahead of print]
32. Leonard SE, Reddie KG, Carroll KS. Mining the thiol proteome for sulfenic acid modifications reveals new targets for oxidation in cells. ACS Chem Biol 2009;4:783-99
33. Reddie KG, Seo YH, Muse WB III, et al. A chemical approach for detecting sulfenic acid-modified proteins in living cells. Mol Biosyst 2008;4:521-31 Provides a method for identifying sulfenated proteins that are targets for S-glutathionylation.
34. Seth D, Stamler JS. The SNO-proteome: causation and classifications. Curr Opin Chem Biol 2010;15:129-36 A good review of protein S-nitrosation.
35. Jarry A, Charrier L, Bou-Hanna C, et al. Position in cell cycle controls the sensitivity of colon cancer cells to nitric oxide-dependent programmed cell death. Cancer Res 2004;64:4227-34 (Pubitemid 38802427)
36. Rossig L, Fichtlscherer B, Breitschopf K, et al. Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem 1999;274:6823-6
37. Klein JA, Ackerman SL. Oxidative stress, cell cycle, and neurodegeneration. J Clin Invest 2003;111:785-93 (Pubitemid 37074950)
38. Huang Z, Pinto JT, Deng H, Richie JP Jr. Inhibition of caspase-3 activity and activation by protein glutathionylation. Biochem Pharmacol 2008;75:2234-44
39. Giustarini D, Milzani A, Aldini G, et al. S-nitrosation versus S-glutathionylation of protein sulfhydryl groups by S-nitrosoglutathione. Antioxid Redox Signal 2005;7:930-9 (Pubitemid 40967144)
40. Martínez-Ruiz A, Lamas S. Signalling by NO-induced protein S-nitrosylation and S-glutathionylation: convergences and divergences. Cardiovasc Res 2007;75:220-8 (Pubitemid 46970703)
41. Foster DB, Van Eyk JE, Marban E, et al. Redox signaling and protein phosphorylation in mitochondria: progress and prospects. J Bioenerg Biomembr 2009;41:159-68
42. Townsend DM, Tew KD. Pharmacology of a mimetic of glutathione disulfide, NOV-002. Biomed Pharmacother 2009;63:75-8
43. Findlay VJ, Townsend DM, Morris TE, et al. A novel role for human sulfiredoxin in the reversal of glutathionylation. Cancer Res 2006;66:6800-6 (Pubitemid 44085640)
44. Peltoniemi MJ, Karala AR, Jurvansuu JK, et al. Insights into deglutathionylation reactions. Different intermediates in the glutaredoxin and protein disulfide isomerase catalyzed reactions are defined by the gamma-linkage present in glutathione. J Biol Chem 2006;281:33107-14 (Pubitemid 46036692)
45. Townsend DM, Manevich Y, He L, et al. Novel role for glutathione S-transferase pi. Regulator of protein S-glutathionylation following oxidative and nitrosative stress. J Biol Chem 2009;284:436-45 An interesting suggestion that GSTs play a role in protein glutathionylation.
46. Schneider A, Brandt W, Wessjohann LA. Influence of pH and flanking serine on the redox potential of S-S and S-Se bridges of Cys-Cys and Cys-Sec peptides. Biol Chem 2007;388:1099-101 (Pubitemid 47584301)
47. Wang PF, Flynn AJ, Naor MM, et al. Exploring the role of the active site cysteine in human muscle creatine kinase. Biochemistry 2006;45:11464-72 (Pubitemid 44453994)
48. Gopalakrishna R, Jaken S. Protein kinase C signaling and oxidative stress. Free Radic Biol Med 2000;28:1349-61 (Pubitemid 30621479)
49. Liu X, Alexander C, Serrano J, et al. Variable reactivity of an engineered cysteine at position 338 in cystic fibrosis transmembrane conductance regulator reflects different chemical states of the thiol. J Biol Chem 2006;281:8275-85 (Pubitemid 43847448)
50. Singleton WC, McInnes KT, Cater MA, et al. Role of glutaredoxin1 and glutathione in regulating the activity of the copper-transporting P-type ATPases, ATP7A and ATP7B. J Biol Chem 2010;285:27111-21
51. Gromer S, Eubel JK, Lee BL, et al. Human selenoproteins at a glance. Cell Mol Life Sci 2005;62:2414-37 A good review of selenoproteins.
52. Huber RE, Criddle RS. Comparison of the chemical properties of selenocysteine and selenocystine with their sulfur analogs. Arch Biochem Biophys 1967;122:164-73
53. Wessjohann LA, Schneider A, Abbas M, et al. Selenium in chemistry and biochemistry in comparison to sulfur. Biol Chem 2007;388:997-1006 A very good comparison of the properties of sulfur versus selenium.
54. Reeves MA, Hoffmann PR. The human selenoproteome: recent insights into functions and regulation. Cell Mol Life Sci 2009;66:2457-78 Summarizes properties of selenoproteins and their distribution, localization and regulation of expression.
55. Lu J, Holmgren A. Selenoproteins. J Biol Chem 2009;284:723-7
56. Sarma BK, Mugesh G. Thiol cofactors for selenoenzymes and their synthetic mimics. Org Biomol Chem 2008;6:965-74
57. Brennan JP, Miller JI, Fuller W, et al. The utility of N,N-biotinyl glutathione disulfide in the study of protein S-glutathiolation. Mol Cell Proteomic 2006;5:215-25 (Pubitemid 43329300)
58. Eaton P. Protein thiol oxidation in health and disease: techniques for measuring disulfides and related modifications in complex protein mixtures. Free Radic Biol Med 2006;40:1889-99 (Pubitemid 43744434)
59. Priora R, Coppo L, Salzano S, et al. Measurement of mixed disulfides including glutathionylated proteins. Methods Enzymol 2010;473:149-59
60. Aesif SW, Janssen-Heininger YM, Reynaert NL. Protocols for the detection of S-glutathionylated and S-nitrosylated proteins in situ. Methods Enzymol 2010;474:289-96
61. Hu Y, Wang T, Liao X, et al. Anti-oxidative stress and beyond: multiple functions of the protein glutathionylation. Protein Pept Lett 2010;17:1234-44
62. Huang Z, Pinto JT, Deng H, et al. Inhibition of caspase-3 activity and activation by protein glutathionylation. Biochem Pharmacol 2008;75:2234-44
63. Azam S, Jouvet N, Jilani A, et al. Human glyceraldehyde-3-phosphate dehydrogenase plays a direct role in reactivating oxidized forms of the DNA repair enzyme APE1. J Biol Chem 2008;283:30632-41
64. Rodriguez-Pascual F, Redondo-Horcajo M, Magan-Marchal N, et al. Glyceraldehyde-3-phosphate dehydrogenase regulates endothelin-1 expression by a novel, redox-sensitive mechanism involving mRNA stability. Mol Cell Biol 2008;28:7139-55
65. Kornberg MD, Sen N, Hara MR, et al. GAPDH mediates nitrosylation of nuclear proteins. Nat Cell Biol 2010;12:1094-100 This paper presents a novel mechanism of nitrosation and expands understanding of signal transduction mechanisms.
66. Nulton-Persson AC, Starke DW, Mieyal JJ, et al. Reversible inactivation of alpha-ketoglutarate dehydrogenase in response to alterations in the mitochondrial glutathione status. Biochemistry 2003;42:4235-42 (Pubitemid 36418317)
67. Applegate MA, Humphries KM, Szweda LI. Reversible inhibition of alpha-ketoglutarate dehydrogenase by hydrogen peroxide: glutathionylation and protection of lipoic acid. Biochemistry 2008;47:473-8
68. Templeton DJ, Aye MS, Rady J, et al. Purification of reversibly oxidized proteins (PROP) reveals a redox switch controlling p38 MAP kinase activity. PLoS One 2010;5:e15012
69. Cross JV, Templeton DJ. Oxidative stress inhibits MEKK1 by site-specific glutathionylation in the ATP-binding domain. Biochem J 2004;381:675-83 (Pubitemid 39120476)
70. Rinna A, Torres M, Forman HJ. Stimulation of the alveolar macrophage respiratory burst by ADP causes selective glutathionylation of protein tyrosine phosphatase 1B. Free Radic Biol Med 2006;41:86-91 (Pubitemid 43866455)
71. Anamika K, Garnier N, Srinivasan N. Functional diversity of human protein kinase splice variants marks significant expansion of human kinome. BMC Genomics 2009;10:622
72. Maher P. Redox control of neural function: background, mechanisms, and significance. Antioxid Redox Signal 2006;8:1941-70 (Pubitemid 46489624)
73. Reynaert NL, van der Vliet A, Guala AS, et al. Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci USA 2006;103:13086-91 (Pubitemid 44338920)
74. Yusuf MA, Chuang T, Bhat GJ, et al. Cys-141 glutathionylation of human p53: Studies using specific polyclonal antibodies in cancer samples and cell lines. Free Radic Biol Med 2010;49:908-17
75. Codutti L, van Ingen H, Vascotto C, et al. The solution structure of DNA-free Pax-8 paired box domain accounts for redox regulation of transcriptional activity in the pax protein family. J Biol Chem 2008;283:33321-8
76. Prinarakis E, Chantzoura E, Thanos D, et al. S-glutathionylation of IRF3 regulates IRF3-CBP interaction and activation of the IFNbeta pathway. EMBO J 2008;27:865-75 (Pubitemid 351417174)
77. Franco R, Cidlowski JA. Apoptosis and glutathione: beyond an antioxidant. Cell Death Differ 2009;16:1303-14
78. Pan S, Berk BC. Glutathiolation regulates tumor necrosis factor-alpha-induced caspase-3 cleavage and apoptosis: key role for glutaredoxin in the death pathway. Circ Res 2007;100:213-19 (Pubitemid 46208721)
79. Meissner F, Molawi K, Zychlinsky A. Superoxide dismutase 1 regulates caspase-1 and endotoxic shock. Nat Immunol 2008;9:866-72
80. Frosali S, Leonini A, Ettorre A, et al. Role of intracellular calcium and S-glutathionylation in cell death induced by a mixture of isothiazolinones in HL60 cells. Biochim Biophys Acta 2009;1793:572-83
81. Markovic J, Borras C, Ortega A, et al. Glutathione is recruited into the nucleus in early phases of cell proliferation. J Biol Chem 2007;282:20416-24 (Pubitemid 47099986)
82. Markovic J, Mora NJ, Broseta AM, et al. Nuclear GSH depletion impairs cell proliferation in 3T3 fibroblasts. PLoS One 2009;29:e6413
83. Soderdahl T, Enoksson M, Lundberg M, et al. Visualization of the compartmentalization of glutathione and protein-glutathione mixed disulfides in cultured cells. FASEB J 2003;17:124-6 This paper presents, using staining and confocal microscopy, the compartmentalization of S-glutathionylation within intact cells.
84. Yang Y, Shi W, Cui N, et al. Oxidative stress inhibits vascular KATP channels by S-glutathionylation. J Biol Chem 2010;285:38641-8
85. Aracena-Parks P, Goonasekera SA, Gilman CP, et al. Identification of cysteines involved in S-nitrosylation, S-glutathionylation, and oxidation to disulfides in ryanodine receptor type 1. J Biol Chem 2006;281:40354-68 (Pubitemid 46043301)
86. Hawkins BJ, Irrinki KM, Mallilankaraman K, et al. S-Glutathionylation activates STIM1 and alters mitochondrial homeostasis. J Cell Biol 2010;190:391-405
87. Wang J, Boja ES, Tan W, et al. Reversible glutathionylation regulates actin polymerization in A431 cells. J Biol Chem 2001;276:47763-6
88. Dalle-Donne I, Giustarini D, Colombo R, et al. S-glutathionylation in human platelets by a thiol-disulfide exchange-independent mechanism. Free Radic Biol Med 2005;38:1501-10 (Pubitemid 40693834)
89. Johansson M, Lundberg M. Glutathionylation of beta-actin via a cysteinyl sulfenic acid intermediary. BMC Biochem 2007;8:26
90. Fiaschi T, Cozzi G, Raugei G, et al. Redox regulation of beta-actin during integrin-mediated cell adhesion. J Biol Chem 2006;281:22983-91
91. Passarelli C, Di Venere A, Piroddi N, et al. Susceptibility of isolated myofibrils to in vitro glutathionylation: potential relevance to muscle functions. Cytoskeleton 2010;67:81-9
92. Sparaco M, Gaeta LM, Santorelli FM, et al. Friedreich's ataxia: oxidative stress and cytoskeletal abnormalities. J Neurol Sci 2009;287:111-18
93. Chen FC, Ogut O. Decline of contractility during ischemia-reperfusion injury: actin glutathionylation and its effect on allosteric interaction with tropomyosin. Am J Physiol Cell Physiol 2006;290:C719-27
94. Hwang C, Sinskey AJ, Lodish HF. Oxidized redox state of glutathione in the endoplasmic reticulum. Science 1992;257:1496-502
95. Townsend DM, Manevich Y, He L, et al. Nitrosative stress-induced S-glutathionylation of protein disulfide isomerase leads to activation of the unfolded protein response. Cancer Res 2009;69:7626-34
96. Demasi M, Piassa Filho GM, Castro LM, et al. Oligomerization of the cysteinyl-rich oligopeptidase EP24.15 is triggered by S-glutathionylation. Free Radic Biol Med 2008;44:1180-90
97. Shi Q, Xu H, Kleinman WA, et al. Novel functions of the alpha-ketoglutarate dehydrogenase complex may mediate diverse oxidant-induced changes in mitochondrial enzymes associated with Alzheimer's disease. Biochim Biophys Acta 2008;1782:229-38
98. Dinoto L, Deture MA, Purich DL. Structural insights into Alzheimer filament assembly pathways based on site-directed mutagenesis and S-glutathionylation of three-repeat neuronal Tau protein. Microsc Res Tech 2005;67:156-63 (Pubitemid 41243633)
99. Di Domenico F, Cenini G, Sultana R, et al. Glutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: implications for AD pathogenesis. Neurochem Res 2009;34:727-33
100. Sampathkumar R, Balasubramanyam M, Sudarslal S, et al. Increased glutathionylated hemoglobin (HbSSG) in type 2 diabetes subjects with microangiopathy. Clin Biochem 2005;38:892-9 (Pubitemid 41319684)
101. Shelton MD, Kern TS, Mieyal JJ. Glutaredoxin regulates nuclear factor kappa-B and intercellular adhesion molecule in Muller cells: model of diabetic retinopathy. J Biol Chem 2007;282:12467-74 (Pubitemid 47100623)
102. Wang W, Oliva C, Li G, et al. Reversible silencing of CFTR chloride channels by glutathionylation. J Gen Physiol 2005;125:127-41 (Pubitemid 40224113)
103. Zaman K, Carraro S, Doherty J, et al. S-Nitrosylating agents: a novel class of compounds that increase cystic fibrosis transmembrane conductance regulator expression and maturation in epithelial cells. Mol Pharmacol 2006;70:1435-42 (Pubitemid 44435996)
104. Craghill J, Cronshaw AD, Harding JJ. The identification of a reaction site of glutathione mixed-disulphide formation on gammaS-crystallin in human lens. Biochem J 2004;379:595-600 The discussion provides an excellent reference to human lens biology.
105. Zhang S, Chai FY, Yan H, et al. Effects of N-acetylcysteine and glutathione ethyl ester drops on streptozotocin-induced diabetic cataract in rats. Mol Vis 2008;14:862-70 (Pubitemid 351715814)
106. Velu CS, Niture SK, Doneanu CE, et al. Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress. Biochemistry 2007;46:7765-80 A mechanistic approach to role of glutathionylation in cell signaling.
107. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-45
108. Voronov E, Shouval DS, Krelin Y, et al. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 2003;100:2645-50 (Pubitemid 36297552)
109. Jung YJ, Isaacs JS, Lee S, et al. IL-1beta-mediated up-regulation of HIF-1alpha via an NFκB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 2003;17:2115-17
110. Shelton MD, Mieyal JJ. Regulation by reversible S-glutathionylation: molecular targets implicated in inflammatory diseases. Mol Cells 2008;25:332-46 A good review of molecular targets of glutathionylation during inflammation.
111. Qanungo S, Starke DW, Pai HV, et al. Glutathione supplementation potentiates hypoxic apoptosis by S-glutathionylation of p65-NFkappaB. J Biol Chem 2007:282:18427-36 Illustrates mechanism of S-glutathionylation control during conditions of hypoxia.
112. Reynaert NL, van der Vliet A, Guala AS, et al. Dynamic redox control of NF-κB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci USA 2006;103:13086-91 (Pubitemid 44338920)
113. Diotte NM, Xiong Y, Gao J, et al. Attenuation of doxorubicin-induced cardiac injury by mitochondrial glutaredoxin 2. Biochim Biophys Acta 2009;1793:427-38
114. Walk TB, Sussmuth R, Kempter C, et al. Identification of unusual amino acids in peptides using automated sequential Edman degradation coupled to direct detection by electrospray-ionization mass spectrometry. Biopolymers 1999;49:329-40 (Pubitemid 29104360)
115. Asaduzzaman SM, Sonomoto K. Lantibiotics: diverse activities and unique modes of action. J Biosci Bioeng 2009;107:475-87
116. Linetsky M, Hill JM, LeGrand RD, et al. Dehydroalanine crosslinks in human lens. Exp Eye Res 2004;79:499-512 (Pubitemid 39223331)
117. Linetsky M, LeGrand RD. Glutathionylation of lens proteins through the formation of thioether bond. Mol Cell Biochem 2005;272:133-44 The first demonstration of irreversible protein glutathionylation in vivo.
118. Bo Li B, van der Donk WA. Identification of essential catalytic residues of the cyclase NisC involved in the biosynthesis of nisin. J Biol Chem 2007;282:21169-75
119. Meister A, Greenstein JP. Glycyl dehydropeptides of leucine, valine, and isoleucine. J Biol Chem 1952;195:849-54
120. Wang H, Zhang J, Xian M. Facile formation of dehydroalanine from S-nitrosocysteines. J Am Chem Soc 2009;131:13238-9
121. McLachlin DT, Chait BT. Improved beta-elimination-based affinity purification strategy for enrichment of phosphopeptides. Anal Chem 2003;75:6826-36 (Pubitemid 37523581)
122. Herbert B, Hopwood F, Oxley D, et al. beta-Elimination: an unexpected artefact in proteome analysis. Proteomics 2003;3:826-31 (Pubitemid 36801668)
123. Bar-Or R, Rael LT, Bar-Or D. Dehydroalanine derived from cysteine is a common post-translational modification in human serum albumin. Rapid Commun Mass Spectrom 2008;22:711-16 (Pubitemid 351373954)
124. Ma S, Caprioli RM, Hill KE, et al. Loss of selenium from selenoproteins: Conversion of selenocysteine to dehydroalanine in vitro. J Am Soc Mass Spectrom 2003;14:593-600 (Pubitemid 36870967)
125. Friedman M. Chemistry, biochemistry, nutrition, and microbiology of lysinoalanine, lanthionine, and histidinoalanine in food and other proteins. J Agric Food Chem 1999;47:1295-319 (Pubitemid 29217113)
126. Snow JT, Finley JW, Friedman M. Relative reactivities of sulfhydryl groups with N-acetyl dehydroalanine and N-acetyl dehydroalanine methyl ester. Int J Pept Protein Res 1976;8:57-64
127. Friedman M, Finley JW, Yeh LS. Reactions of proteins with dehydroalanines. Adv Exp Med Biol 1977;86B:213-24
128. Bernardes GJ, Chalker JM, Errey JC, et al. Facile conversion of cysteine and alkyl cysteines to dehydroalanine on protein surfaces: versatile and switchable access to functionalized proteins. J Am Chem Soc 2008;130:5052-3 (Pubitemid 351537062)
129. Amini A, Nilsson E. Quantitative analysis of polypeptide pharmaceuticals by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Pharm Biomed Anal 2008;46:411-17
130. Jeong J, Jung Y, Na S, et al. Novel oxidative modifications in redox-active cysteine residues. Mol Cell Proteomics 2010. [Epub ahead of print]
131. Stein TP, Leskiw MJ, Buzby GP, et al. Measurement of protein synthesis rates with [15N]glycine. Am J Physiol 1980;239:E294-300
132. Cho CS, Lee S, Lee GT, et al. Irreversible inactivation of glutathione peroxidase 1 and reversible inactivation of peroxiredoxin II by H2O2 in red blood cells. Antioxid Redox Signal 2010;12:1235-46
133. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969;27:502-22
134. Iwamoto T, Hiraku Y, Oikawa S, et al. DNA intrastrand cross-link at the 5′-GA-3′ sequence formed by busulfan and its role in the cytotoxic effect. Cancer Sci 2004;95:454-8 (Pubitemid 38832691)
135. Ritter CA, Bohnenstengel F, Hofmann U, et al. Determination of tetrahydrothiophene formation as a probe of in vitro busulfan metabolism by human glutathione S-transferase A1-1: use of highly sensitive gas chromatographic-mass spectrometric method. J Chromatog B Biomed Sci Appl 1999;730:25-31 (Pubitemid 29290602)
136. Czerwinski M, Gibbs JP, Slattery JT. Busulfan conjugation by glutathione S-transferases alpha, mu, and pi. Drug Metab Dispos 1996;24:1015-19 (Pubitemid 26314555)
137. Gibbs JP, Czerwinski M, Slattery JT. Busulfan-glutathione conjugation catalyzed by human liver cytosolic glutathione S-transferases. Cancer Res 1996;56:3678-81 (Pubitemid 26272012)
138. Ritter CA, Sperker B, Grube M, et al. Overexpression of glutathione S-transferase A1-1 in ECV 304 cells protects against busulfan mediated G2-arrest and induces tissue factor expression. Br J Pharmacol 2002;137:1100-6 (Pubitemid 35440751)
139. Roberts JJ, Warwick GP. The mode of action of alkylating agents. III. The formation of 3- hydroxytetrahydrothiophene-1:1-dioxide from 1:4-dimethanesulphonyloxybutane (myleran), S-beta-L-alanyltetrahydrothiophenium mesylate, tetrahydrothiophene and tetrahydrothiophene-1:1-dioxide in the rat, rabbit and mouse. Biochem Pharmacol 1961;6:217-27
140. Cooper AJL, Younis IR, Niatsetskaya ZV, et al. Metabolism of the cysteine S-conjugate of busulfan involves a beta-lyase reaction. Drug Metab Dispos 2008;36:1546-52
141. Younis IR, Elliott M, Peer CJ, et al. Dehydroalanine analog of glutathione: an electrophilic busulfan metabolite that binds to human glutathione S-transferase A1-1. J Pharmacol Exp Ther 2008;327:770-6 Demonstration of the formation of a dehydroalanyl analogue of GSH, the formation of GSG and inhibition of a GST by GSG.
142. Kalayoglu-Besisik S, Yenerei MN, Caliskan Y, et al. Time-related changes in the incidence, severity, and clinical outcome of hepatic veno-occlusive disease in hematopoietic cell transplantation patients during the past 10 years. Transplant Proc 2005;37:2285-9 (Pubitemid 40956433)
143. Holmstrom G, Borgstrom B, Calissendorff B. Cataract formation after bone marrow transplantation: relation to conditioning regimen. Acta Ophthalmol Scand 2002;80:211-15 (Pubitemid 34406857)
144. Wadleigh M, Ho V, Momtaz P, et al. Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment. Curr Opin Hematol 2003;10:451-62 (Pubitemid 37352490)
145. Kera Y, Penttila KE, Lindros KO. Glutathione replenishment capacity is lower in isolated perivenous than in periportal hepatocytes. Biochem J 1988;254:411-17
146. Deleve LD. Dacarbazine toxicity in murine liver cells: a model of hepatic endothelial injury and glutathione defense. J Pharmacol Exp Ther 1994;268:1261-70 (Pubitemid 24100340)
147. Deleve LD. Glutathione defense in non-parenchymal cells. Semin Liver Dis 1998;18:403-13 (Pubitemid 29011043)
148. Srivastava A, Poonkuzhali B, Shaji RV, et al. Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation. Blood 2004;104:1574-7 (Pubitemid 39166540)
149. DeLeve LD, Wang X. Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes. Pharmacology 2000;60:143-54 (Pubitemid 30189528)
150. Bouligand J, Deroussent A, Simonnard N, et al. Induction of glutathione synthesis explains pharmacodynamics of high-dose busulfan in mice and highlights putative mechanisms of drug interaction. Drug Metab Dispos 2007;35:306-14 (Pubitemid 46148745)
151. Zeiger E, Pagano DA. Mutagenicity of the human carcinogen treosulphan in Salmonella. Environ Mol Mutagen 1989;13:343-6 (Pubitemid 19199205)
152. Werner S, Mendoza A, Hilger RA, et al. Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma. Cancer Chemother Pharmacol 2008;62:19-31 (Pubitemid 351537841)
153. Feyerabend S, Feil G, Krug J, et al. Cytotoxic effects of treosulfan on prostate cancer cell lines. Anticancer Res 2007;27:2403-8 (Pubitemid 47228081)
154. Armstrong DK, Gordon GB, Hilton J, et al. Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance. Cancer Res 1992;52:1416-21
155. Westerhof GR, Ploemacher RE, Boudewijn A, et al. Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients. Cancer Res 2000;60:5470-8
156. Onkenhout W, van Loon WM, Buijs W, et al. Biotransformation and quantitative determination of sulfur-containing metabolites of 1,4-dibromobutane in the rat. Drug Metab Dispos 1986;14:608-12 (Pubitemid 16026725)
157. Anders MW. Chemical toxicology of reactive intermediates formed by the glutathione-dependent bioactivation of halogen-containing compounds. Chem Res Toxicol 2008;21:145-59 A good review of how the formation of glutathione S-conjugates with certain halogenated xenobiotics can lead to bioactivation (toxification) rather than detoxification.
158. Guengerich FP. Metabolism and genotoxicity of dihaloalkanes. Adv Pharmacol 1994;27:211-36
159. Bentley TW. Additivity rules using similarity models for chemical reactivity: calculation and interpretation of electrofugality and nucleofugality. Chemistry 2006;25:6514-20 A good review for those interested in the chemistry of elimination reactions.
160. Zhu X, Gallogly MM, Mieyal JJ, et al. Covalent cross-linking of glutathione and carnosine to proteins by 4-oxo-2-nonenal. Chem Res Toxicol 2009;22:1050-9
161. Choi C, Dimitrov IE, Douglas D, et al. Improvement of resolution for brain coupled metabolites by optimized 1H MRS at 7T. NMR Biomed 2010;23:1044-52 This article highlights the increasing use of NMR techniques to non-invasively measure GSH in human brain.
162. Choi IY, Lee SP, Denney D, Lynch S. Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T. Mult Scler 2011;17:289-96
163. Matsuzawa D, Hashimoto K. Magnetic resonance spectroscopy study of the antioxidant defense system in schizophrenia. Antioxid Redox Signal 2010. [Epub ahead of print]
164. Wright AJ, Fellows GA, Griffiths JR, et al. Ex-vivo HRMAS of adult brain tumours: metabolite quantification and assignment of tumour biomarkers. Mol Cancer 2010;9:66
165. Thelwall PE, Yemin AY, Gillian TL, et al. Noninvasive in vivo detection of glutathione metabolism in tumors. Cancer Res 2005;65:10149-53 (Pubitemid 41743701)
166. Tew KD, Townsend DM. Redox platforms in cancer drug discovery and development. Curr Opin Chem Biol 2011;15:156-61